TOF-话题@MedSci

#TOF#

24篇内容 | 864人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1987473, encodeId=fc33198e47380, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=FDA批准tofacitinib治疗类风湿关节炎, objectType=article, longId=10908, objectId=07911090866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07911090866, replyNumber=0, likeNumber=29, createdTime=2013-07-09, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07911090866, moduleTitle=FDA批准tofacitinib治疗类风湿关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07911090866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987474, encodeId=dbd2198e474fa, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究, objectType=article, longId=17915, objectId=dbba1e915b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbba1e915b2, replyNumber=0, likeNumber=32, createdTime=2014-03-24, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbba1e915b2, moduleTitle=A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbba1e915b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987472, encodeId=58ec198e4725c, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效, objectType=article, longId=8928, objectId=d169892874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d169892874, replyNumber=0, likeNumber=35, createdTime=2013-06-29, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d169892874, moduleTitle=NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d169892874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987471, encodeId=2373198e471ff, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, objectType=article, longId=5996, objectId=78a6599680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a6599680, replyNumber=0, likeNumber=28, createdTime=2012-12-09, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a6599680, moduleTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a6599680)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TOF

2020-05-29

daviiliu (审核中...)

前往app查看评论内容

#TOF#

FDA批准tofacitinib治疗类风湿关节炎

2013-07-09

daviiliu (审核中...)

前往app查看评论内容

#TOF#

A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究

2014-03-24

daviiliu (审核中...)

前往app查看评论内容

#TOF#

NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效

2013-06-29

daviiliu (审核中...)

前往app查看评论内容

#TOF#

辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决

2012-12-09

科室
- - 订阅+
  - 更多科室
工具
服务